Anixa Biosciences Inc

General ticker "ANIX" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $97.1M

Anixa Biosciences Inc does not follow the US Stock Market performance with the rate: -16.1%.

Estimated limits based on current volatility of 2.6%: low 2.53$, high 2.67$

Factors to consider:

  • Company does not operate outside North America (retrieved using AI)
  • Price in estimated range
  • Earnings for 9 months up through Q3 are close to our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-10-31 to 2025-10-30

  • 2023-10-31 to 2024-10-30 estimated range: [2.04$, 4.25$]
  • 2024-10-30 to 2025-10-30 estimated range: [1.99$, 4.18$]

Financial Metrics affecting the ANIX estimates:

  • Negative: Non-GAAP EPS, $ of -0.32 <= 0.10
  • Negative: Operating profit margin, % of -98.13 <= 1.03
  • Negative: Operating cash flow per share per price, % of -5.76 <= 2.35
  • Negative: negative Net income
  • Positive: -0.96 < Investing cash flow per share, $ of -0.18
  • Negative: Industry earnings per price (median), % of -26.08 <= 1.31

Similar symbols

Short-term ANIX quotes

Long-term ANIX plot with estimates

Financial data

YTD 2021-10-31 2022-10-31 2023-10-31
Operating Revenue $0.51MM $0.00MM $0.21MM
Operating Expenses $13.65MM $13.88MM $11.22MM
Operating Income $-13.14MM $-13.88MM $-11.01MM
Non-Operating Income $0.01MM $0.10MM $1.08MM
Interest Expense $0.00MM $0.00MM $0.00MM
R&D Expense $6.19MM $6.70MM $4.77MM
Income(Loss) $-13.13MM $-13.77MM $-9.93MM
Profit(Loss) $-13.13MM $-13.77MM $-9.93MM
Stockholders Equity $35.44MM $29.05MM $24.34MM
Inventory $0.00MM $0.05MM $0.00MM
Assets $36.26MM $30.41MM $25.52MM
Operating Cash Flow $-4.94MM $-6.49MM $-6.21MM
Investing Cash Flow $-3.92MM $-10.73MM $-5.60MM
Financing Cash Flow $31.57MM $0.45MM $0.37MM
Earnings Per Share* $-0.45 $-0.44 $-0.32

* EPS are Split Adjusted, recent splits may be reflected with a delay.